Comparative Analysis of the Effectiveness of Methotrexate Co-Administration with Baricitinib in Rheumatoid Arthritis Treatment
OBJECTIVES: To evaluate the effect of methotrexate (MTX) co-administration with baricitinib (BAR) in rheumatoid arthritis (RA) treatment using a multicenter registry. METHODS: A total of 296 patients with RA treated with BAR were included (167 with MTX and 129 without MTX). Treatment effectiveness over 52 weeks was evaluated using propensity score-based overlap weighting to adjust for baseline differences. Group-based trajectory modeling (GBTM) was applied to identify distinct longitudinal response patterns. RESULTS: After overlap weighting, baseline characteristics were successfully balanced between groups (standardized mean differences <0.1). No significant differences were observed between the -MTX and +MTX groups in treatment retention (76.3% vs. 83.7%, p=0.213), CDAI scores at week 52 (5.7 [95% CI 4.2-7.1] vs. 5.8 [95% CI 4.5-7.1], p=0.90), or remission rates (32.1% vs. 34.5%, p=0.70). GBTM identified four distinct trajectories of disease activity; however, the distribution of MTX use did not differ across trajectory groups. CONCLUSIONS: After adjustment for baseline differences, MTX co-administration was not associated with improved clinical outcomes or response trajectories during BAR therapy. These findings may inform treatment decisions for patients unable to receive concomitant MTX.
Authors
- Shiro Imagama (ORCID: https://orcid.org/0000-0002-6951-8575)
- Nobunori Takahashi (ORCID: https://orcid.org/0000-0001-6937-3567)
- Yuji Hirano (ORCID: https://orcid.org/0000-0002-0422-8139)
- Tomonori Kobayakawa (ORCID: https://orcid.org/0009-0002-6814-9920)
- Tsuyoshi Watanabe (ORCID: https://orcid.org/0000-0002-4246-751X)
- Toki Takemoto (ORCID: https://orcid.org/0000-0001-6717-9904)
- Toshihisa Kojima (ORCID: https://orcid.org/0000-0001-8497-0212)
- Yutaka Yoshioka
- Yasumori Sobue (ORCID: https://orcid.org/0000-0002-8936-4278)
- Tsuyoshi Nishiume
- Masahiro Hanabayashi
- Kenya Terabe (ORCID: https://orcid.org/0000-0001-6469-1312)
- Shuji Asai (ORCID: https://orcid.org/0000-0002-4030-8793)
- Mihoko Kato (ORCID: https://orcid.org/0009-0001-4846-5953)
- Yasuhide Kanayama (ORCID: https://orcid.org/0000-0002-2409-1619)
- Takefumi Kato
- Takayoshi Fujibayashi
- Hiroyuki Matsubara
- Mochihito Suzuki
- Tatsuo Watanabe
Institutions
- Aichi Medical University (JP)
- Konan Kosei Hospital (JP)
- Aichi Medical University Hospital (JP)
- Hekinan Technical High School (JP)
- Ichinomiya Municipal City Hospital (JP)
- Okazaki City Hospital (JP)
- Shizuoka City Hospital (JP)
- Japanese Red Cross Nagoya Daiichi Hospital (JP)
- Shizuoka General Hospital (JP)
- National Hospital Organization (JP)
- Toyota Kosei Hospital (JP)
- Anjo Kosei Hospital (JP)
- Toyohashi Municipal Hospital (JP)
- Nagoya Medical Center (JP)
- National Center for Geriatrics and Gerontology (JP)
- Daido Hospital (JP)
- Hekinan Municipal Hospital (JP)
- National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology (JP)
- Daido University (JP)
- Nagoya University (JP)
Publication Details
- Journal
- Modern Rheumatology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1093/mr/roag099
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00